Danish Pharmacovigilance Update, April 2017

22 May 2017

In this issue

  • Ciprofloxacin and risk of polyneuropathy and tendon disease/disorder
  • Rosuvastatin and risk of renal effects and rhabdomyolysis
  • The DKMA’s annual pharmacovigilance report 2016
  • Report on the use of and ADR reports on selected biological medicinal products now available
  • EU's list of recommendations on safety signals
  • Most recent Direct Healthcare Professional Communications (DHPCs)


Danish Pharmacovigilance Update, April 2017

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.